Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (211-220 of 294) with videos related to

Pageof 30
Sort By:
Blood|April 20, 2021
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCLAnja Schmitt, Wendan Xu, Philip Bucher, et al.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
The Oncologist|March 29, 2020
Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II TrialsGabriele Reinartz, Caroline Molavi Tabrizi, Ruediger Liersch, et al.
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Frontiers in Oncology|March 7, 2022
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective AnalysisHira Mian, Christine Eisfeld, Christopher P Venner, et al.
Molecular Oncology|January 18, 2025
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survivalBarnabas Irmer, Darius Wlochowitz, Carolin Krekeler, et al.
Blood|March 8, 2024
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemiaEloísa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz, et al.
Blood|April 28, 2006
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Barbara Wassmann, Heike Pfeifer, Nicola Goekbuget, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALLMatthias Stelljes, Simon Raffel, Nael Alakel, et al.
Blood|November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphomaAndre Weilemann, Michael Grau, Tabea Erdmann, et al.
Pageof 30

Showing results (211-220 of 294) with videos related to

Sort By:
Pageof 30
Blood|April 20, 2021
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCLAnja Schmitt, Wendan Xu, Philip Bucher, et al.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
The Oncologist|March 29, 2020
Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II TrialsGabriele Reinartz, Caroline Molavi Tabrizi, Ruediger Liersch, et al.
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Frontiers in Oncology|March 7, 2022
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective AnalysisHira Mian, Christine Eisfeld, Christopher P Venner, et al.
Molecular Oncology|January 18, 2025
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survivalBarnabas Irmer, Darius Wlochowitz, Carolin Krekeler, et al.
Blood|March 8, 2024
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemiaEloísa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz, et al.
Blood|April 28, 2006
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Barbara Wassmann, Heike Pfeifer, Nicola Goekbuget, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALLMatthias Stelljes, Simon Raffel, Nael Alakel, et al.
Blood|November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphomaAndre Weilemann, Michael Grau, Tabea Erdmann, et al.
Pageof 30